0QLQ.L
Price:
$417.5
Market Cap:
$5.67B
Ypsomed Holding AG, together with its subsidiaries, develops, manufactures, and sells injection and infusion systems for pharmaceutical and biotechnology companies. The company operates in two segments, Ypsomed Delivery Systems and Ypsomed Diabetes Care. The Ypsomed Delivery Systems segment provides various injection systems, such as pen injectors, auto injectors, patch injectors, and wearable injectors, as well as other smart devices. This segment offers its products under the YDS brand. The Ypsomed Diabetes Care segment sells and trades in insulin pumps, infusion sets, pen needles, blood glucose monitoring systems, accessories, and other day-to-day items for diabetics. This segment offers ...[Read more]
Industry
Medical - Equipment & Services
IPO Date
2016-05-19
Stock Exchange
LSE
Ticker
0QLQ.L
According to Ypsomed Holding AG’s latest financial reports and current stock price. The company's current ROE is 13.45%. This represents a change of 103.26% compared to the average of 6.62% of the last 4 quarters.
The mean historical ROE of Ypsomed Holding AG over the last ten years is 10.50%. The current 13.45% ROE has changed 28.11% with respect to the historical average. Over the past ten years (40 quarters), 0QLQ.L's ROE was at its highest in in the September 2018 quarter at 14.91%. The ROE was at its lowest in in the March 2021 quarter at -0.18%.
Average
10.50%
Median
12.78%
Minimum
1.47%
Maximum
15.88%
Discovering the peaks and valleys of Ypsomed Holding AG ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 300.49%
Maximum Annual ROE = 15.88%
Minimum Annual Increase = -80.43%
Minimum Annual ROE = 1.47%
Year | ROE | Change |
---|---|---|
2025 | 12.87% | 1.48% |
2024 | 12.69% | 39.13% |
2023 | 9.12% | 54.91% |
2022 | 5.89% | 300.49% |
2021 | 1.47% | -52.70% |
2020 | 3.11% | -80.43% |
2019 | 15.88% | 4.15% |
2018 | 15.24% | -0.53% |
2017 | 15.32% | 14.61% |
2016 | 13.37% | 65.89% |
The current ROE of Ypsomed Holding AG (0QLQ.L) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
11.56%
5-year avg
8.41%
10-year avg
10.50%
Ypsomed Holding AG’s ROE is less than Axon Enterprise, Inc. (14.86%), less than Corcept Therapeutics Incorporated (20.46%), less than Kardex Holding AG (27.72%),
Company | ROE | Market cap |
---|---|---|
14.86% | $61.11B | |
20.46% | $7.17B | |
27.72% | $2.19B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Ypsomed Holding AG using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Ypsomed Holding AG or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Ypsomed Holding AG's ROE?
How is the ROE calculated for Ypsomed Holding AG (0QLQ.L)?
What is the highest ROE for Ypsomed Holding AG (0QLQ.L)?
What is the 3-year average ROE for Ypsomed Holding AG (0QLQ.L)?
What is the 5-year average ROE for Ypsomed Holding AG (0QLQ.L)?
How does the current ROE for Ypsomed Holding AG (0QLQ.L) compare to its historical average?